The Swedish medical technology company, Bonesupport, in Lund, which develops synthetic, injectable ceramic bone substitute, has signed its first commercial distribution agreement in North America. The agreement with the American company Signus Medical LLC covers exclusive sales rights in ten key states and is an important breakthrough in the U.S. market.
